DETECTION OF MESSENGER-RNA FOR THE CYTOKINES, INTERLEUKIN-1-ALPHA AND INTERLEUKIN-8, IN CORNEAS FROM PATIENTS WITH PSEUDOPHAKIC BULLOUS KERATOPATHY

被引:0
作者
ROSENBAUM, JT
PLANCK, SR
HUANG, XN
RICH, L
ANSEL, JC
机构
[1] OREGON HLTH SCI UNIV,DEPT MED,PORTLAND,OR 97201
[2] OREGON HLTH SCI UNIV,DEPT CELL BIOL & ANAT,PORTLAND,OR 97201
[3] OREGON HLTH SCI UNIV,DEPT DERMATOL,PORTLAND,OR 97201
[4] VET AFFAIRS MED CTR,DERMATOL SERV,PORTLAND,OR
关键词
CORNEA; CYTOKINES; FUCHS DYSTROPHY; POLYMERASE CHAIN REACTION (PCR); PSEUDOPHAKIC BULLOUS KERATOPATHY;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. Cytokines have been implicated in corneal inflammatory diseases. The authors sought to determine if corneal diseases with different patterns of inflammation are accompanied by characteristic patterns of cytokine expression. Methods. The authors used reverse transcription-polymerase chain reaction to detect mRNA for 12 specific cytokines from patients with Fuch's dystrophy (n = 7), pseudophakic bullous keratopathy (n = 12), or normal corneas (n = 4). Results. Using Wilcoxon rank sum analysis, mRNA for interleukin (IL)-1 alpha or IL-8 was significantly more abundant in corneas from patients with pseudophakic bullous keratopathy relative to either comparison group. mRNA for the T-cell marker, CD4, and for T-cell derived cytokines, IL-2, IL-4, and interferon gamma, could not be detected in any corneal sample. Message for IL-1 receptor antagonist and transforming growth factor-beta(1) or -beta(2) was readily detectable in most corneas regardless of diagnosis. Conclusion. The findings indicate that the pattern of cytokine mRNA expression reflects differences in the pathogenesis of these corneal diseases.
引用
收藏
页码:2151 / 2155
页数:5
相关论文
共 15 条
  • [1] FUCHS ENDOTHELIAL DYSTROPHY OF THE CORNEA
    ADAMIS, AP
    FILATOV, V
    TRIPATHI, BJ
    TRIPATHI, RC
    [J]. SURVEY OF OPHTHALMOLOGY, 1993, 38 (02) : 149 - 168
  • [2] INVIVO ANGIOGENIC ACTIVITY OF INTERLEUKINS
    BENEZRA, D
    HEMO, I
    MAFTZIR, G
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1990, 108 (04) : 573 - 576
  • [3] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [4] CUBITT CL, 1994, J IMMUNOL, V153, P232
  • [5] DEVOS AF, 1994, INVEST OPHTH VIS SCI, V35, P1100
  • [6] ELNER VM, 1991, INVEST OPHTH VIS SCI, V32, P1120
  • [7] GIRARD MT, 1991, INVEST OPHTH VIS SCI, V32, P2441
  • [8] HENDRICKS RL, 1992, J IMMUNOL, V149, P3023
  • [9] HENDRICKS RL, 1991, INVEST OPHTH VIS SCI, V32, P854
  • [10] OKAMOTO J, 1991, INVEST OPHTH VIS SCI, V32, P1070